Trial Profile
Clinical Trials Insight: 700057321
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Jul 2010
Price :
$35
*
At a glance
- Drugs Talampanel (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 01 Jul 2010 New trial record